197 related articles for article (PubMed ID: 17067263)
1. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.
McDougal JS; Parekh BS; Peterson ML; Branson BM; Dobbs T; Ackers M; Gurwith M
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):945-52. PubMed ID: 17067263
[TBL] [Abstract][Full Text] [Related]
2. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.
Parekh BS; Hanson DL; Hargrove J; Branson B; Green T; Dobbs T; Constantine N; Overbaugh J; McDougal JS
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):265-73. PubMed ID: 20954834
[TBL] [Abstract][Full Text] [Related]
3. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay.
Hu DJ; Vanichseni S; Mock PA; Young NL; Dobbs T; Byers RH; Choopanya K; van Griensven F; Kitayaporn D; McDougal JS; Tappero JW; Mastro TD; Parekh BS
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):727-30. PubMed ID: 14585202
[TBL] [Abstract][Full Text] [Related]
4. Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam.
Sexton CJ; Costenbader EC; Vinh DT; Chen PL; Hoang TV; Lan NT; Feldblum P; Kim A; Giang le T
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):866-73. PubMed ID: 21936716
[TBL] [Abstract][Full Text] [Related]
5. Comparison of methods to detect recent HIV type 1 infection in cross-sectionally collected specimens from a cohort of female sex workers in the Dominican Republic.
Gupta SB; Murphy G; Koenig E; Adon C; Beyrer C; Celentano D; Khawaja S; Sifakis F; Parry JV; Straus W
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1475-80. PubMed ID: 18160004
[TBL] [Abstract][Full Text] [Related]
6. HIV incidence determination in the United States: a multiassay approach.
Laeyendecker O; Brookmeyer R; Cousins MM; Mullis CE; Konikoff J; Donnell D; Celum C; Buchbinder SP; Seage GR; Kirk GD; Mehta SH; Astemborski J; Jacobson LP; Margolick JB; Brown J; Quinn TC; Eshleman SH
J Infect Dis; 2013 Jan; 207(2):232-9. PubMed ID: 23129760
[TBL] [Abstract][Full Text] [Related]
7. Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007.
Xu J; Wang H; Jiang Y; Ding G; Jia M; Wang G; Chu J; Smith K; Sharp GB; Chen RY; Jin X; Dong R; Han X; Shang H; Wang N
Int J Infect Dis; 2010 Jul; 14(7):e608-12. PubMed ID: 20102792
[TBL] [Abstract][Full Text] [Related]
8. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
[TBL] [Abstract][Full Text] [Related]
9. Is the bed capture enzyme immunoassay useful for surveillance in concentrated epidemics? The case of female sex workers in Indonesia.
Morineau G; Magnani R; Nurhayati A; Bollen L; Mustikawati DE
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):634-42. PubMed ID: 21706941
[TBL] [Abstract][Full Text] [Related]
10. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay.
Hargrove JW; Humphrey JH; Mutasa K; Parekh BS; McDougal JS; Ntozini R; Chidawanyika H; Moulton LH; Ward B; Nathoo K; Iliff PJ; Kopp E
AIDS; 2008 Feb; 22(4):511-8. PubMed ID: 18301064
[TBL] [Abstract][Full Text] [Related]
11. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion.
Dobbs T; Kennedy S; Pau CP; McDougal JS; Parekh BS
J Clin Microbiol; 2004 Jun; 42(6):2623-8. PubMed ID: 15184443
[TBL] [Abstract][Full Text] [Related]
12. [A system review on the application of BED-capture enzyme immunoassay in detecting new HIV-1 infection].
Tao J; Zhao J; Liu Y; Meng LZ; Yu SC; Jiang Y; Xiao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Feb; 32(2):177-81. PubMed ID: 21518629
[TBL] [Abstract][Full Text] [Related]
13. Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.
Duong YT; Dobbs T; Mavengere Y; Manjengwa J; Rottinghaus E; Saito S; Bock N; Philip N; Justman J; Bicego G; Nkengasong JN; Parekh BS
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):896-905. PubMed ID: 31204867
[TBL] [Abstract][Full Text] [Related]
14. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing.
Bärnighausen T; Wallrauch C; Welte A; McWalter TA; Mbizana N; Viljoen J; Graham N; Tanser F; Puren A; Newell ML
PLoS One; 2008; 3(11):e3640. PubMed ID: 18982059
[TBL] [Abstract][Full Text] [Related]
15. Estimates of human immunodeficiency virus incidence among female sex workers in north central Nigeria: implications for HIV clinical trials.
Forbi JC; Entonu PE; Mwangi LO; Agwale SM
Trans R Soc Trop Med Hyg; 2011 Nov; 105(11):655-60. PubMed ID: 21872898
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China.
Jiang Y; Wang M; Ni M; Duan S; Wang Y; Feng J; Xiao Y; Dong Y; Wang D; Han M; Xiang L; Ma L; Zhou Q
AIDS; 2007 Dec; 21 Suppl 8():S47-51. PubMed ID: 18172391
[TBL] [Abstract][Full Text] [Related]
17. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
Konikoff J; Brookmeyer R; Longosz AF; Cousins MM; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Justman JE; Hodder SL; Quinn TC; Eshleman SH; Laeyendecker O
PLoS One; 2013; 8(12):e82772. PubMed ID: 24386116
[TBL] [Abstract][Full Text] [Related]
18. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
Karita E; Price M; Hunter E; Chomba E; Allen S; Fei L; Kamali A; Sanders EJ; Anzala O; Katende M; Ketter N;
AIDS; 2007 Feb; 21(4):403-8. PubMed ID: 17301558
[TBL] [Abstract][Full Text] [Related]
19. Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence.
McNicholl JM; McDougal JS; Wasinrapee P; Branson BM; Martin M; Tappero JW; Mock PA; Green TA; Hu DJ; Parekh B;
PLoS One; 2011 Mar; 6(3):e14748. PubMed ID: 21408214
[TBL] [Abstract][Full Text] [Related]
20. Temporal trends in HIV Type 1 incidence among inner-city childbearing women in Atlanta: use of the IgG-capture BED-enzyme immunoassay.
Nesheim S; Parekh B; Sullivan K; Bulterys M; Dobbs T; Lindsay M; Cashat-Cruz M; Byers B; Lee F
AIDS Res Hum Retroviruses; 2005 Jun; 21(6):537-44. PubMed ID: 15989458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
